Oppenheimer initiates Raptor Pharmaceutical At Market Perform

By: via Benzinga
Analysts at Oppenheimer initiated coverage on Raptor Pharmaceutical (NASDAQ: RPTP) with a Market Perform rating. Raptor ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.